2.10
Precedente Chiudi:
$2.09
Aprire:
$2.1
Volume 24 ore:
48,909
Relative Volume:
0.34
Capitalizzazione di mercato:
$36.42M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.48%
6M Prestazione:
-23.64%
1 anno Prestazione:
-45.74%
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MURA
Mural Oncology Plc
|
2.10 | 36.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Citadel Group discloses 1.38% stake in Mural Oncology By Investing.com - Investing.com South Africa
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
What drives Mural Oncology plc stock priceLow Risk Investment Ideas & Rapid Capital Gain - earlytimes.in
Is Mural Oncology plc stock attractive for ETFsJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Mural Oncology plc stock remains a top recommendation - newser.com
Will Mural Oncology plc stock benefit from green energy trendsTrade Entry Report & Safe Capital Growth Plans - newser.com
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Citadel discloses 1.31% stake in Mural Oncology - Investing.com India
Citadel discloses 1.31% stake in Mural Oncology By Investing.com - Investing.com Canada
What candlestick patterns are forming on Mural Oncology plcJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Mural Oncology plc a candidate for recovery playJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Citadel Group discloses 1.3% stake in Mural Oncology By Investing.com - Investing.com South Africa
Citadel Group discloses 1.3% stake in Mural Oncology - Investing.com India
Why Mural Oncology plc stock is favored by pension fundsWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Citadel Group discloses 1.26% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.26% stake in Mural Oncology - Investing.com India
Is it too late to sell Mural Oncology plcPortfolio Profit Report & Community Supported Trade Ideas - newser.com
How Mural Oncology plc stock performs during Fed tightening cyclesPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Combining price and volume data for Mural Oncology plc - newser.com
Is Mural Oncology plc stock attractive for growth ETFsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Analysis and ForecastPrice Action Trading & Discover Top Gainers in Every Sector - earlytimes.in
What analysts say about Mural Oncology plc stockSector Rotation Strategies & Get The Analyst Consensus With One Click - earlytimes.in
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):